Pre-earnings options volume in Ginkgo Bioworks is 1.7x normal with calls leading puts 19:7. Implied volatility suggests the market is anticipating a move near 12.2%, or 18c, after results are released. Median move over the past eight quarters is 4.3%.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on DNA:
- Cathie Wood’s ARK Investment bought 473K shares of Ginkgo Bioworks today
- Xwell, Ginkgo Bioworks implement expanded CDC TGS program
- Ginkgo Bioworks and Xwell expand work with CDC to test priority pathogens
- Ginkgo Bioworks’ partnership with Penn State University supported by USDA grant
- Ginkgo Bioworks and Government of Serbia collaborating in bioeconomy